nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—Procedural pain—Telbivudine—hepatitis B	0.0447	0.0452	CcSEcCtD
Rifaximin—Abdominal pain lower—Telbivudine—hepatitis B	0.0402	0.0406	CcSEcCtD
Rifaximin—Ascites—Entecavir—hepatitis B	0.0342	0.0346	CcSEcCtD
Rifaximin—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0189	0.0191	CcSEcCtD
Rifaximin—Laryngeal pain—Telbivudine—hepatitis B	0.0187	0.0189	CcSEcCtD
Rifaximin—Rhinorrhoea—Telbivudine—hepatitis B	0.0158	0.0159	CcSEcCtD
Rifaximin—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0149	0.0151	CcSEcCtD
Rifaximin—Neck pain—Telbivudine—hepatitis B	0.0129	0.0131	CcSEcCtD
Rifaximin—Influenza like illness—Telbivudine—hepatitis B	0.0124	0.0125	CcSEcCtD
Rifaximin—Respiratory tract infection—Lamivudine—hepatitis B	0.0115	0.0116	CcSEcCtD
Rifaximin—Abdominal pain upper—Entecavir—hepatitis B	0.0103	0.0104	CcSEcCtD
Rifaximin—Rifampicin—CYP2A6—hepatitis B	0.0102	1	CrCbGaD
Rifaximin—Pain in extremity—Telbivudine—hepatitis B	0.00927	0.00937	CcSEcCtD
Rifaximin—Migraine—Telbivudine—hepatitis B	0.00913	0.00922	CcSEcCtD
Rifaximin—Neutropenia—Entecavir—hepatitis B	0.00912	0.00922	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Entecavir—hepatitis B	0.00907	0.00916	CcSEcCtD
Rifaximin—Rhinorrhoea—Lamivudine—hepatitis B	0.00889	0.00898	CcSEcCtD
Rifaximin—Hyperglycaemia—Entecavir—hepatitis B	0.0088	0.00889	CcSEcCtD
Rifaximin—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00861	0.0087	CcSEcCtD
Rifaximin—Abdominal pain upper—Telbivudine—hepatitis B	0.00847	0.00856	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00835	0.00844	CcSEcCtD
Rifaximin—Haematuria—Entecavir—hepatitis B	0.00829	0.00838	CcSEcCtD
Rifaximin—Nasopharyngitis—Telbivudine—hepatitis B	0.00829	0.00838	CcSEcCtD
Rifaximin—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00809	0.00818	CcSEcCtD
Rifaximin—Abdominal distension—Telbivudine—hepatitis B	0.00807	0.00815	CcSEcCtD
Rifaximin—Bone disorder—Lamivudine—hepatitis B	0.00797	0.00805	CcSEcCtD
Rifaximin—Oedema peripheral—Entecavir—hepatitis B	0.00769	0.00777	CcSEcCtD
Rifaximin—Abdominal discomfort—Telbivudine—hepatitis B	0.00768	0.00776	CcSEcCtD
Rifaximin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00756	0.00764	CcSEcCtD
Rifaximin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00752	0.0076	CcSEcCtD
Rifaximin—Neutropenia—Telbivudine—hepatitis B	0.00749	0.00757	CcSEcCtD
Rifaximin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00747	0.00755	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00745	0.00752	CcSEcCtD
Rifaximin—Mental disorder—Entecavir—hepatitis B	0.00684	0.00691	CcSEcCtD
Rifaximin—Malnutrition—Entecavir—hepatitis B	0.0068	0.00687	CcSEcCtD
Rifaximin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00663	0.0067	CcSEcCtD
Rifaximin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00654	0.0066	CcSEcCtD
Rifaximin—Urine output increased—Lamivudine—hepatitis B	0.00651	0.00658	CcSEcCtD
Rifaximin—Back pain—Adefovir Dipivoxil—hepatitis B	0.00642	0.00648	CcSEcCtD
Rifaximin—Hypoaesthesia—Telbivudine—hepatitis B	0.00638	0.00645	CcSEcCtD
Rifaximin—Pharyngitis—Telbivudine—hepatitis B	0.00637	0.00643	CcSEcCtD
Rifaximin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00613	0.00619	CcSEcCtD
Rifaximin—Polyuria—Lamivudine—hepatitis B	0.00595	0.00601	CcSEcCtD
Rifaximin—Cough—Adefovir Dipivoxil—hepatitis B	0.00579	0.00585	CcSEcCtD
Rifaximin—Mediastinal disorder—Telbivudine—hepatitis B	0.00578	0.00584	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00575	0.00581	CcSEcCtD
Rifaximin—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00565	0.0057	CcSEcCtD
Rifaximin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00565	0.0057	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00561	0.00567	CcSEcCtD
Rifaximin—Malnutrition—Telbivudine—hepatitis B	0.00558	0.00564	CcSEcCtD
Rifaximin—Anaphylactic shock—Entecavir—hepatitis B	0.00555	0.0056	CcSEcCtD
Rifaximin—Infection—Entecavir—hepatitis B	0.00551	0.00557	CcSEcCtD
Rifaximin—Nervous system disorder—Entecavir—hepatitis B	0.00544	0.0055	CcSEcCtD
Rifaximin—Back pain—Telbivudine—hepatitis B	0.0054	0.00546	CcSEcCtD
Rifaximin—Skin disorder—Entecavir—hepatitis B	0.00539	0.00544	CcSEcCtD
Rifaximin—Muscle spasms—Telbivudine—hepatitis B	0.00537	0.00542	CcSEcCtD
Rifaximin—Hypoglycaemia—Lamivudine—hepatitis B	0.00535	0.00541	CcSEcCtD
Rifaximin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00531	0.00536	CcSEcCtD
Rifaximin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00526	0.00531	CcSEcCtD
Rifaximin—Ill-defined disorder—Telbivudine—hepatitis B	0.00518	0.00523	CcSEcCtD
Rifaximin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00516	0.00521	CcSEcCtD
Rifaximin—Migraine—Lamivudine—hepatitis B	0.00514	0.0052	CcSEcCtD
Rifaximin—Malaise—Telbivudine—hepatitis B	0.00504	0.00509	CcSEcCtD
Rifaximin—Insomnia—Entecavir—hepatitis B	0.00502	0.00507	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00493	0.00498	CcSEcCtD
Rifaximin—Cough—Telbivudine—hepatitis B	0.00487	0.00492	CcSEcCtD
Rifaximin—Dehydration—Lamivudine—hepatitis B	0.00486	0.00491	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Entecavir—hepatitis B	0.00479	0.00484	CcSEcCtD
Rifaximin—Fatigue—Entecavir—hepatitis B	0.00478	0.00483	CcSEcCtD
Rifaximin—Abdominal pain upper—Lamivudine—hepatitis B	0.00477	0.00482	CcSEcCtD
Rifaximin—Chest pain—Telbivudine—hepatitis B	0.00475	0.0048	CcSEcCtD
Rifaximin—Arthralgia—Telbivudine—hepatitis B	0.00475	0.0048	CcSEcCtD
Rifaximin—Myalgia—Telbivudine—hepatitis B	0.00475	0.0048	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00472	0.00477	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00471	0.00475	CcSEcCtD
Rifaximin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00471	0.00475	CcSEcCtD
Rifaximin—Discomfort—Telbivudine—hepatitis B	0.0047	0.00475	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00467	0.00472	CcSEcCtD
Rifaximin—Nasopharyngitis—Lamivudine—hepatitis B	0.00467	0.00472	CcSEcCtD
Rifaximin—Abdominal distension—Lamivudine—hepatitis B	0.00455	0.00459	CcSEcCtD
Rifaximin—Gastrointestinal pain—Entecavir—hepatitis B	0.00454	0.00458	CcSEcCtD
Rifaximin—Dysphagia—Lamivudine—hepatitis B	0.00452	0.00456	CcSEcCtD
Rifaximin—Nervous system disorder—Telbivudine—hepatitis B	0.00447	0.00452	CcSEcCtD
Rifaximin—Skin disorder—Telbivudine—hepatitis B	0.00443	0.00447	CcSEcCtD
Rifaximin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00443	0.00447	CcSEcCtD
Rifaximin—Sweating increased—Lamivudine—hepatitis B	0.0044	0.00444	CcSEcCtD
Rifaximin—Abdominal pain—Entecavir—hepatitis B	0.00439	0.00443	CcSEcCtD
Rifaximin—Body temperature increased—Entecavir—hepatitis B	0.00439	0.00443	CcSEcCtD
Rifaximin—Abdominal discomfort—Lamivudine—hepatitis B	0.00433	0.00437	CcSEcCtD
Rifaximin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00428	0.00432	CcSEcCtD
Rifaximin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00428	0.00432	CcSEcCtD
Rifaximin—Neutropenia—Lamivudine—hepatitis B	0.00422	0.00427	CcSEcCtD
Rifaximin—Dysuria—Lamivudine—hepatitis B	0.00422	0.00427	CcSEcCtD
Rifaximin—Pollakiuria—Lamivudine—hepatitis B	0.00417	0.00422	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00415	0.00419	CcSEcCtD
Rifaximin—Insomnia—Telbivudine—hepatitis B	0.00412	0.00416	CcSEcCtD
Rifaximin—Hyperglycaemia—Lamivudine—hepatitis B	0.00407	0.00412	CcSEcCtD
Rifaximin—Depression—Lamivudine—hepatitis B	0.00402	0.00406	CcSEcCtD
Rifaximin—Asthenia—Entecavir—hepatitis B	0.00398	0.00402	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00393	0.00398	CcSEcCtD
Rifaximin—Fatigue—Telbivudine—hepatitis B	0.00393	0.00397	CcSEcCtD
Rifaximin—Pain—Telbivudine—hepatitis B	0.0039	0.00394	CcSEcCtD
Rifaximin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00388	0.00392	CcSEcCtD
Rifaximin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00383	0.00387	CcSEcCtD
Rifaximin—Epistaxis—Lamivudine—hepatitis B	0.0038	0.00384	CcSEcCtD
Rifaximin—Diarrhoea—Entecavir—hepatitis B	0.0038	0.00383	CcSEcCtD
Rifaximin—Feeling abnormal—Telbivudine—hepatitis B	0.00376	0.00379	CcSEcCtD
Rifaximin—Gastrointestinal pain—Telbivudine—hepatitis B	0.00373	0.00376	CcSEcCtD
Rifaximin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0037	0.00374	CcSEcCtD
Rifaximin—Dizziness—Entecavir—hepatitis B	0.00367	0.00371	CcSEcCtD
Rifaximin—Rhinitis—Lamivudine—hepatitis B	0.00362	0.00366	CcSEcCtD
Rifaximin—Abdominal pain—Telbivudine—hepatitis B	0.0036	0.00364	CcSEcCtD
Rifaximin—Body temperature increased—Telbivudine—hepatitis B	0.0036	0.00364	CcSEcCtD
Rifaximin—Hypoaesthesia—Lamivudine—hepatitis B	0.0036	0.00363	CcSEcCtD
Rifaximin—Pharyngitis—Lamivudine—hepatitis B	0.00359	0.00362	CcSEcCtD
Rifaximin—Vomiting—Entecavir—hepatitis B	0.00353	0.00356	CcSEcCtD
Rifaximin—Rash—Entecavir—hepatitis B	0.0035	0.00353	CcSEcCtD
Rifaximin—Dermatitis—Entecavir—hepatitis B	0.00349	0.00353	CcSEcCtD
Rifaximin—Headache—Entecavir—hepatitis B	0.00348	0.00351	CcSEcCtD
Rifaximin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00344	0.00348	CcSEcCtD
Rifaximin—Rash—Adefovir Dipivoxil—hepatitis B	0.00341	0.00345	CcSEcCtD
Rifaximin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00341	0.00344	CcSEcCtD
Rifaximin—Headache—Adefovir Dipivoxil—hepatitis B	0.00339	0.00343	CcSEcCtD
Rifaximin—Nausea—Entecavir—hepatitis B	0.0033	0.00333	CcSEcCtD
Rifaximin—Asthenia—Telbivudine—hepatitis B	0.00327	0.0033	CcSEcCtD
Rifaximin—Mediastinal disorder—Lamivudine—hepatitis B	0.00326	0.00329	CcSEcCtD
Rifaximin—Pruritus—Telbivudine—hepatitis B	0.00322	0.00326	CcSEcCtD
Rifaximin—Nausea—Adefovir Dipivoxil—hepatitis B	0.00322	0.00325	CcSEcCtD
Rifaximin—Malnutrition—Lamivudine—hepatitis B	0.00315	0.00318	CcSEcCtD
Rifaximin—Diarrhoea—Telbivudine—hepatitis B	0.00312	0.00315	CcSEcCtD
Rifaximin—Flatulence—Lamivudine—hepatitis B	0.0031	0.00313	CcSEcCtD
Rifaximin—Back pain—Lamivudine—hepatitis B	0.00304	0.00308	CcSEcCtD
Rifaximin—Muscle spasms—Lamivudine—hepatitis B	0.00303	0.00306	CcSEcCtD
Rifaximin—Dizziness—Telbivudine—hepatitis B	0.00301	0.00304	CcSEcCtD
Rifaximin—Tremor—Lamivudine—hepatitis B	0.00295	0.00298	CcSEcCtD
Rifaximin—Ill-defined disorder—Lamivudine—hepatitis B	0.00292	0.00295	CcSEcCtD
Rifaximin—Anaemia—Lamivudine—hepatitis B	0.00291	0.00294	CcSEcCtD
Rifaximin—Vomiting—Telbivudine—hepatitis B	0.0029	0.00293	CcSEcCtD
Rifaximin—Angioedema—Lamivudine—hepatitis B	0.00288	0.00291	CcSEcCtD
Rifaximin—Rash—Telbivudine—hepatitis B	0.00287	0.0029	CcSEcCtD
Rifaximin—Dermatitis—Telbivudine—hepatitis B	0.00287	0.0029	CcSEcCtD
Rifaximin—Headache—Telbivudine—hepatitis B	0.00286	0.00288	CcSEcCtD
Rifaximin—Malaise—Lamivudine—hepatitis B	0.00284	0.00287	CcSEcCtD
Rifaximin—Vertigo—Lamivudine—hepatitis B	0.00283	0.00286	CcSEcCtD
Rifaximin—Syncope—Lamivudine—hepatitis B	0.00282	0.00285	CcSEcCtD
Rifaximin—Loss of consciousness—Lamivudine—hepatitis B	0.00277	0.00279	CcSEcCtD
Rifaximin—Cough—Lamivudine—hepatitis B	0.00275	0.00277	CcSEcCtD
Rifaximin—Nausea—Telbivudine—hepatitis B	0.00271	0.00273	CcSEcCtD
Rifaximin—Arthralgia—Lamivudine—hepatitis B	0.00268	0.00271	CcSEcCtD
Rifaximin—Myalgia—Lamivudine—hepatitis B	0.00268	0.00271	CcSEcCtD
Rifaximin—Chest pain—Lamivudine—hepatitis B	0.00268	0.00271	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00266	0.00269	CcSEcCtD
Rifaximin—Discomfort—Lamivudine—hepatitis B	0.00265	0.00267	CcSEcCtD
Rifaximin—Dry mouth—Lamivudine—hepatitis B	0.00262	0.00265	CcSEcCtD
Rifaximin—Confusional state—Lamivudine—hepatitis B	0.00259	0.00262	CcSEcCtD
Rifaximin—Anaphylactic shock—Lamivudine—hepatitis B	0.00257	0.00259	CcSEcCtD
Rifaximin—Infection—Lamivudine—hepatitis B	0.00255	0.00258	CcSEcCtD
Rifaximin—Shock—Lamivudine—hepatitis B	0.00253	0.00255	CcSEcCtD
Rifaximin—Nervous system disorder—Lamivudine—hepatitis B	0.00252	0.00254	CcSEcCtD
Rifaximin—Skin disorder—Lamivudine—hepatitis B	0.00249	0.00252	CcSEcCtD
Rifaximin—Hyperhidrosis—Lamivudine—hepatitis B	0.00248	0.00251	CcSEcCtD
Rifaximin—Anorexia—Lamivudine—hepatitis B	0.00245	0.00247	CcSEcCtD
Rifaximin—Hypotension—Lamivudine—hepatitis B	0.0024	0.00242	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00234	0.00236	CcSEcCtD
Rifaximin—Insomnia—Lamivudine—hepatitis B	0.00232	0.00235	CcSEcCtD
Rifaximin—Dyspnoea—Lamivudine—hepatitis B	0.00229	0.00231	CcSEcCtD
Rifaximin—Decreased appetite—Lamivudine—hepatitis B	0.00223	0.00226	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00222	0.00224	CcSEcCtD
Rifaximin—Fatigue—Lamivudine—hepatitis B	0.00221	0.00224	CcSEcCtD
Rifaximin—Constipation—Lamivudine—hepatitis B	0.0022	0.00222	CcSEcCtD
Rifaximin—Pain—Lamivudine—hepatitis B	0.0022	0.00222	CcSEcCtD
Rifaximin—Feeling abnormal—Lamivudine—hepatitis B	0.00212	0.00214	CcSEcCtD
Rifaximin—Gastrointestinal pain—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Rifaximin—Urticaria—Lamivudine—hepatitis B	0.00204	0.00206	CcSEcCtD
Rifaximin—Abdominal pain—Lamivudine—hepatitis B	0.00203	0.00205	CcSEcCtD
Rifaximin—Body temperature increased—Lamivudine—hepatitis B	0.00203	0.00205	CcSEcCtD
Rifaximin—Hypersensitivity—Lamivudine—hepatitis B	0.00189	0.00191	CcSEcCtD
Rifaximin—Asthenia—Lamivudine—hepatitis B	0.00184	0.00186	CcSEcCtD
Rifaximin—Pruritus—Lamivudine—hepatitis B	0.00182	0.00184	CcSEcCtD
Rifaximin—Diarrhoea—Lamivudine—hepatitis B	0.00176	0.00178	CcSEcCtD
Rifaximin—Dizziness—Lamivudine—hepatitis B	0.0017	0.00172	CcSEcCtD
Rifaximin—Vomiting—Lamivudine—hepatitis B	0.00163	0.00165	CcSEcCtD
Rifaximin—Rash—Lamivudine—hepatitis B	0.00162	0.00164	CcSEcCtD
Rifaximin—Dermatitis—Lamivudine—hepatitis B	0.00162	0.00163	CcSEcCtD
Rifaximin—Headache—Lamivudine—hepatitis B	0.00161	0.00163	CcSEcCtD
Rifaximin—Nausea—Lamivudine—hepatitis B	0.00153	0.00154	CcSEcCtD
